Seminaarit ja kongressit

– Clinical relevance of Cardiopulmonary Exercise Testing in pulmonary & cardiac diseases

Date: October 5, 2021, 5pm CET (11am ET)
Register: You need to register to this online webinar

Cardiopulmonary exercise testing (CPET) is a test performed to determine an overview of the person’s cardiopulmonary, circulatory and metabolic health as a response to physical work load by measuring metabolic gas exchange alongside a number of other physiological parameters such as blood pressure, heart rate, etc. In the clinical world, it is used as a diagnostic tool to identify the possible physiological limitation in both children and adult patient groups leading to a specific disease or disability, be it pulmonary, cardiac, peripheral, metabolic, or other limitations. During this webinar, our speakers will review and share their experience with the CPET to identify most important clinical factors to assist with diagnosis, therapy and prognosis of various pulmonary and cardiac diseases.

Dr. Gregory D. Lewis - Assoc. Prof. at Harvard Medical School,  Assoc. Physician at Massachusetts General Hospital On the Scientific Advisory Board for NXT Therapeutics

Dr. Karl P. Sylvester - Head of Joint Respiratory Physiology Respiratory Physiology, Royal Papworth Hospital, NHS Foundation Trust Papworth Everard, Cambridgeshire


– Understanding and Implementing the ATS/ERS 2019 Spirometry Guidelines into your Pulmonary Function Laboratory; what’s new, what’s improved

Date: Nov. 3, 2021, 5pm CET (10am CT)
Register: You need to register to this online webinar

The new spirometry standards and consensus, underpinned by previous guidelines, provide recommendations with the aim of increasing the accuracy, precision, and quality of spirometric measurements and improving the patient experience

During this webinar, Dr. Brian Graham one of the authors of the 2019 spirometry guidelines, will review and describe why labs should work to follow these new recommendations, and how improvements in determining: quality criteria, instrument quality control and management, staff competency, and test session grading improve confidence and accuracy of the physician interpretation.

Dr. Brian Graham
Professor Emeritus at the University of Saskatchewan, Saskatoon, Canada in the Division of Respirology, Critical Care and Sleep Medicine


– Understanding the 2017 ERS/ATS Methacholine Guidelines and how to implement the latest guideline in your PF laboratory

Date: Dec. 1, 2021, 5pm CET (10am CT)
Register: You need to register to this online webinar

The gold standard to determine airway hyperresponsiveness, used to characterize the likelihood of asthma, remains the bronchial provocation test using methacholine. The long awaited ERS/ATS guidelines published in 2017, diverge from the former 1999 guidelines and make explicit recommendations around such topics as: nebulizer characteristics, mode of delivery of methacholine, concentration of methacholine for dosing schedule, provocative dose, and characterizing severity of AHR, are among only some of the updates.

Dr. Frans de Jongh will review the details of the new guidelines, as well as contrasting the changes from former standards where such things as PC20 vs PD20 are concerned, and recommendations to coach the maneuver as tidal breathing versus inhalation to TLC and why these maneuvers should be avoided.

Dr. Ir. Frans. de Jongh, PhD - Scientific Researcher - Assistant Professor - Pulmonary Physiologist - Head of Lung Function Laboratory